These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical laboratory aspects of the use of morpholevocycline in calculous pyelonephritis]. Kurashkin AG. Sov Med; 1978 Oct; (10):18-21. PubMed ID: 152468 [No Abstract] [Full Text] [Related]
3. [Comparative effectiveness of sigmamycin and olemorphocycline in the treatment of exacerbations of chronic pyelonephritis]. Soloshenko LV, Volynskiĭ ME, Gurina IK, Temper TM. Vrach Delo; 1974 Mar; (3):65-6. PubMed ID: 4283234 [No Abstract] [Full Text] [Related]
4. [Urinary microflora in calculous pyelonephritis and its role in recurrent stone formation]. Liul'ko AV, Kropinov PI, Agafonov NV. Vrach Delo; 1982 Jul; (7):67-70. PubMed ID: 7135910 [No Abstract] [Full Text] [Related]
5. [Direct bacteriological studies of patients with calculous pyelonephritis]. Anastasov G, Todorova L, Panchev P, Raĭchev G. Vutr Boles; 1985 Jul; 24(6):94-100. PubMed ID: 4095985 [Abstract] [Full Text] [Related]
6. [Results of using morphocycline for the treatment of fresh, uncomplicated gonorrhea in men]. Dashevskiĭ NV. Antibiotiki; 1976 Sep; 21(9):852-4. PubMed ID: 136924 [Abstract] [Full Text] [Related]
7. [Drug sensitivity of urinary microflora and the effect of treatment in exacerbated chronic pyelonephritis]. Robeva R, Gruev I, Vasilev T, Neshev Kh. Vutr Boles; 1986 Sep; 25(3):68-74. PubMed ID: 3765581 [Abstract] [Full Text] [Related]
8. [Regional intraosseous infusion of morphocycline and olemorphocycline in the treatment of severe forms of purulent infection of the hand and fingers]. Kosachev ID. Vestn Khir Im I I Grek; 1973 Jul; 111(7):63-7. PubMed ID: 4776766 [No Abstract] [Full Text] [Related]
10. [Specific immunotherapy in complex treatment of chronic calculous pyelonephritis]. Uchugina AF, Krasil'nikova MV. Urol Nefrol (Mosk); 1966 Oct; 31(6):17-20. PubMed ID: 6002433 [No Abstract] [Full Text] [Related]
11. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Peterson J, Kaul S, Khashab M, Fisher A, Kahn JB. Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477 [Abstract] [Full Text] [Related]
12. [Experiences with nephrolith in the treatment of patients with kidney calculi]. Modliński L. Z Urol Nephrol; 1977 Jun; 70(6):429-35. PubMed ID: 333815 [Abstract] [Full Text] [Related]
13. [Comparative evaluation of the blood coagulation in non-calculous and calculous pyelonephritis]. Bezborod'ko BN, Sakhno LP. Vrach Delo; 1971 Aug; 8():9-12. PubMed ID: 5143079 [No Abstract] [Full Text] [Related]
14. [The effect of tetracycline, tetraolean and olemorphocycline on indices of non-specific bodily resistance and nervous system excitability under normal conditions and in aseptic inflammation]. Plaksin AI, Plaksina AN, Kolevatova EA, Semenova ZN. Antibiotiki; 1974 Apr; 19(4):363-8. PubMed ID: 4282567 [No Abstract] [Full Text] [Related]